"There is panic in EMs due to strengthening of the dollar and the accelerated pace of the tapering by the Fed. Global fund managers have become cautious on EMs, as returns could get diluted," said Tirthankar Patnaik, director and chief economist, Religare Capital Markets.
The US central bank, on Wednesday, had announced a $10-billion reduction in its stimulus package to $65 billion a month.
As a result, currencies and equities in the Asian region took a beating last week. The Indian markets touched the lowest level since November 2013. The Sensex ended the week at 20,513, down 2.9 per cent, while the Nifty was down 2.8 per cent at 6,089.
Analysts said the Indian markets might see fewer inflows. Last week, FIIs were net sellers in shares worth Rs 3,220 crore, while domestic investors were net buyers at Rs 1,771 crore.
In January, foreign institutions were net buyers at Rs 714 crore, while they had bought shares worth Rs 16,085 crore in December 2013. Domestic institution investors were net sellers in January at Rs 1,455 crore.
The markets will also keenly eye the HSBC manufacturing and services data to be released on Monday and Wednesday, respectively. The gross domestic product (GDP) forecast for the current financial year, expected to be below five per cent as against the government estimate of five per cent, will also be announced this week.
"Unless there is no significant upside or downside in the numbers, there will not be much of an impact on the markets," said Ramanathan K, executive director and chief investment officer, ING Investment Management.
Analysts said the decline in the market would be led by financials. The banking sector stocks continued to remain out of favour. The pace of selling was aggravated by the decision of the Reserve Bank of India of rate rise on Tuesday. Sector analysts said asset quality concerns had now spread to the non-banking financial companies, as well as the private banks.
Stocks such as those of ICICI Bank, Union Bank of India, YES Bank and Bank of Baroda among others, might see further declines. Any interim rise in prices should be seen as an opportunity to trim positions, analysts added.
The earnings season, nearing its end, might lead to some stock-specific movement, analysts said. Reliance Capital, BHEL, Ambuja Cements, Tata Power and Ranbaxy Laboratories are some of the companies expected to declare their third quarter earnings numbers.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)